{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:57:37Z","timestamp":1793779057221,"version":"4.6.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41390-020-0750-8","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T06:02:18Z","timestamp":1578722538000},"page":"176-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Surfactant replacement therapy: from biological basis to current clinical practice"],"prefix":"10.1038","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-4067","authenticated-orcid":false,"given":"Roland","family":"Hentschel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Bohlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"van Kaam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Danhaive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"750_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chemphyslip.2014.09.002","volume":"185","author":"E Parra","year":"2015","unstructured":"Parra, E. & Perez-Gil, J. Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem. Phys. Lipids 185, 153\u2013175 (2015).","journal-title":"Chem. Phys. Lipids"},{"key":"750_CR2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bbamem.2012.02.021","volume":"1818","author":"LN Suri","year":"2012","unstructured":"Suri, L. N. et al. Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity. Biochim. Biophys. Acta 1818, 1581\u20131589 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"750_CR3","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI117173","volume":"93","author":"LM Nogee","year":"1994","unstructured":"Nogee, L. M. et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J. Clin. Invest. 93, 1860\u20131863 (1994).","journal-title":"J. Clin. Invest."},{"key":"750_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20110681","volume":"438","author":"E Parra","year":"2011","unstructured":"Parra, E. et al. A combined action of pulmonary surfactant proteins SP-B and SP-C modulates permeability and dynamics of phospholipid membranes. Biochem. J. 438, 555\u2013564 (2011).","journal-title":"Biochem. J."},{"key":"750_CR5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ejhg.2015.45","volume":"23","author":"D Peca","year":"2015","unstructured":"Peca, D. et al. Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations. Eur. J. Hum. Genet. 23, 1033\u20131041 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"750_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/BST20150100","volume":"43","author":"D Peca","year":"2015","unstructured":"Peca, D. et al. ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system. Biochem. Soc. Trans. 43, 913\u2013919 (2015).","journal-title":"Biochem. Soc. Trans."},{"key":"750_CR7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05491-z","volume":"9","author":"C McCarthy","year":"2018","unstructured":"McCarthy, C. et al. Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis. Nat. Commun. 9, 3127 (2018).","journal-title":"Nat. Commun."},{"key":"750_CR8","first-page":"11","volume":"5","author":"JA Clements","year":"1962","unstructured":"Clements, J. A. Surface phenomena in relation to pulmonary function. Physiologist 5, 11\u201328 (1962).","journal-title":"Physiologist"},{"key":"750_CR9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ppul.22885","volume":"49","author":"G Stichtenoth","year":"2014","unstructured":"Stichtenoth, G. et al. Surface tension of airway aspirates withdrawn during neonatal resuscitation reflects lung maturity. Pediatr. Pulmonol. 49, 751\u2013756 (2014).","journal-title":"Pediatr. Pulmonol."},{"key":"750_CR10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000353363","volume":"104","author":"R Bhatia","year":"2013","unstructured":"Bhatia, R. et al. The stable microbubble test for determining continuous positive airway pressure (CPAP) success in very preterm infants receiving nasal CPAP from birth. Neonatology 104, 188\u2013193 (2013).","journal-title":"Neonatology"},{"key":"750_CR11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PCC.0b013e3182196e9a","volume":"13","author":"AC Vieira","year":"2012","unstructured":"Vieira, A. C. et al. Lamellar body count and stable microbubble test on tracheal aspirates from infants for the diagnosis of respiratory distress syndrome. Pediatr. Crit. Care Med. 13, 178\u2013182 (2012).","journal-title":"Pediatr. Crit. Care Med."},{"key":"750_CR12","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1194\/jlr.D800029-JLR200","volume":"49","author":"A Ravasio","year":"2008","unstructured":"Ravasio, A., Cruz, A., Perez-Gil, J. & Haller, T. High-throughput evaluation of pulmonary surfactant adsorption and surface film formation. J. Lipid Res. 49, 2479\u20132488 (2008).","journal-title":"J. Lipid Res."},{"key":"750_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/pr.2014.176","volume":"77","author":"O Danhaive","year":"2015","unstructured":"Danhaive, O. et al. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B. Pediatr. Res. 77, 340\u2013346 (2015).","journal-title":"Pediatr. Res."},{"key":"750_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/rccm.201602-0422LE","volume":"194","author":"D De Luca","year":"2016","unstructured":"De Luca, D. et al. Hypothermia and meconium aspiration syndrome: International Multicenter Retrospective Cohort Study. Am. J. Respir. Crit. Care Med. 194, 381\u2013384 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"750_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2016.11.057","volume":"182","author":"C Autilio","year":"2017","unstructured":"Autilio, C. et al. A noninvasive surfactant adsorption test predicting the need for surfactant therapy in preterm infants treated with continuous positive airway pressure. J. Pediatr. 182, 66\u201373 (2017).","journal-title":"J. Pediatr."},{"key":"750_CR16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/pr.2015.165","volume":"78","author":"MC Hutten","year":"2015","unstructured":"Hutten, M. C. et al. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation. Pediatr. Res. 78, 664\u2013669 (2015).","journal-title":"Pediatr. Res."},{"key":"750_CR17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/PDR.0b013e31821be094","volume":"70","author":"ML Siew","year":"2011","unstructured":"Siew, M. L. et al. Surfactant increases the uniformity of lung aeration at birth in ventilated preterm rabbits. Pediatr. Res. 70, 50\u201355 (2011).","journal-title":"Pediatr. Res"},{"key":"750_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000153095","volume":"95","author":"A Hamvas","year":"2009","unstructured":"Hamvas, A. et al. Developmental and genetic regulation of human surfactant protein B in vivo. Neonatology 95, 117\u2013124 (2009).","journal-title":"Neonatology"},{"key":"750_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/pr.2015.173","volume":"79","author":"M Griese","year":"2016","unstructured":"Griese, M. et al. Surfactant proteins in pediatric interstitial lung disease. Pediatr. Res. 79, 34\u201341 (2016).","journal-title":"Pediatr. Res."},{"key":"750_CR20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1203\/00006450-199902000-00015","volume":"45","author":"PE Cogo","year":"1999","unstructured":"Cogo, P. E. et al. Endogenous surfactant metabolism in critically ill infants measured with stable isotope labeled fatty acids. Pediatr. Res. 45, 242\u2013246 (1999).","journal-title":"Pediatr. Res."},{"key":"750_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/ajrccm.161.5.9905088","volume":"161","author":"M Torresin","year":"2000","unstructured":"Torresin, M. et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am. J. Respir. Crit. Care Med. 161, 584\u2013589 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"750_CR22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000155755.27716.04","volume":"57","author":"P Cogo","year":"2005","unstructured":"Cogo, P. et al. Surfactant-associated protein B kinetics in vivo in newborn infants by stable isotopes. Pediatr. Res. 57, 519\u2013522 (2005).","journal-title":"Pediatr. Res."},{"key":"750_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.00032212","volume":"41","author":"PE Cogo","year":"2013","unstructured":"Cogo, P. E. et al. Impaired surfactant protein B synthesis in infants with congenital diaphragmatic hernia. Eur. Respir. J. 41, 677\u2013682 (2013).","journal-title":"Eur. Respir. J."},{"key":"750_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/pr.2015.123","volume":"78","author":"S D\u2019Aronco","year":"2015","unstructured":"D\u2019Aronco, S. et al. Surfactant protein B and A concentrations are increased in neonatal pneumonia. Pediatr. Res. 78, 401\u2013406 (2015).","journal-title":"Pediatr. Res."},{"key":"750_CR25","doi-asserted-by":"crossref","first-page":"e950","DOI":"10.1542\/peds.2009-0126","volume":"124","author":"PE Cogo","year":"2009","unstructured":"Cogo, P. E. et al. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics 124, e950\u2013e957 (2009).","journal-title":"Pediatrics"},{"key":"750_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/jp.2011.125","volume":"33","author":"R Ramanathan","year":"2013","unstructured":"Ramanathan, R., Bhatia, J. J., Sekar, K. & Ernst, F. R. Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study. J. Perinatol. 33, 119\u2013125 (2013).","journal-title":"J. Perinatol."},{"key":"750_CR27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpeds.2013.04.053","volume":"163","author":"A Trembath","year":"2013","unstructured":"Trembath, A. et al. Comparative effectiveness of surfactant preparations in premature infants. J. Pediatr. 163, 955\u2013960 (2013).","journal-title":"J. Pediatr."},{"key":"750_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1651-2227.1994.tb13036.x","volume":"83","author":"L Gortner","year":"1994","unstructured":"Gortner, L. et al. High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr. 83, 135\u2013141 (1994).","journal-title":"Acta Paediatr."},{"key":"750_CR29","first-page":"CD010249","volume":"12","author":"N Singh","year":"2015","unstructured":"Singh, N. et al. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst. Rev. 12, CD010249 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.jp.7211754","volume":"27","author":"K Bohlin","year":"2007","unstructured":"Bohlin, K. et al. Implementation of surfactant treatment during continuous positive airway pressure. J. Perinatol. 27, 422\u2013427 (2007).","journal-title":"J. Perinatol."},{"key":"750_CR31","doi-asserted-by":"publisher","unstructured":"Tridente, A., De Martino, L. & De Luca, D. Porcine vs bovine surfactant therapy forpreterm neonates with RDS: systematic review with biological plausibility andpragmatic meta-analysis of respiratory outcomes. Respir. Res. [online]. https:\/\/doi.org\/10.1186\/s12931-019-0979-0.","DOI":"10.1186\/s12931-019-0979-0"},{"key":"750_CR32","first-page":"CD000144","volume":"8","author":"S Ardell","year":"2015","unstructured":"Ardell, S., Pfister, R. H. & Soll, R. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst. Rev. 8, CD000144 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR33","first-page":"1","volume":"88","author":"RH Phibbs","year":"1991","unstructured":"Phibbs, R. H. et al. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 88, 1\u20139 (1991).","journal-title":"Pediatrics"},{"key":"750_CR34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.2004-2231","volume":"115","author":"SK Sinha","year":"2005","unstructured":"Sinha, S. K. et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 115, 1030\u20131038 (2005).","journal-title":"Pediatrics"},{"key":"750_CR35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1542\/peds.2004-2183","volume":"115","author":"FR Moya","year":"2005","unstructured":"Moya, F. R. et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 115, 1018\u20131029 (2005).","journal-title":"Pediatrics"},{"key":"750_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jamp.2009.0758","volume":"23","author":"NN Finer","year":"2010","unstructured":"Finer, N. N. et al. An open label, pilot study of Aerosurf\u00ae combined with nCPAP to prevent RDS in preterm neonates. Aerosol Med. Pulm. Drug Deliv. 23, 303\u2013309 (2010).","journal-title":"Aerosol Med. Pulm. Drug Deliv."},{"key":"750_CR37","doi-asserted-by":"crossref","first-page":"F497","DOI":"10.1136\/archdischild-2017-312722","volume":"102","author":"DG Sweet","year":"2017","unstructured":"Sweet, D. G. et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch. Dis. Child Fetal Neonatal Ed. 102, F497\u2013F503 (2017).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"750_CR38","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1194\/jlr.M085431","volume":"59","author":"J Madsen","year":"2018","unstructured":"Madsen, J. et al. Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice. J. Lipid Res. 59, 1880\u20131892 (2018).","journal-title":"J. Lipid Res."},{"key":"750_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14787210.2017.1259067","volume":"15","author":"K Glaser","year":"2017","unstructured":"Glaser, K. et al. Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes. Expert Rev. Anti. Infect. Ther. 15, 181\u2013189 (2017).","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"750_CR40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(17)30214-X","volume":"5","author":"D De Luca","year":"2017","unstructured":"De Luca, D. et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir. Med. 5, 657\u2013666 (2017).","journal-title":"Lancet Respir. Med."},{"key":"750_CR41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/00006450-199006000-00011","volume":"27","author":"T Yamada","year":"1990","unstructured":"Yamada, T., Ikegami, M. & Jobe, A. H. Effects of surfactant subfractions on preterm rabbit lung function. Pediatr. Res. 27, 592\u2013598 (1990).","journal-title":"Pediatr. Res."},{"key":"750_CR42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.colsurfb.2007.10.009","volume":"62","author":"HW Taeusch","year":"2008","unstructured":"Taeusch, H. W., Dybbro, E. & Lu, K. W. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol. Colloids Surf. B Biointerfaces 62, 243\u2013249 (2008).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"750_CR43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1203\/00006450-199804000-00018","volume":"43","author":"C Fajardo","year":"1998","unstructured":"Fajardo, C. et al. Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits. Pediatr. Res. 43, 542\u2013547 (1998).","journal-title":"Pediatr. Res."},{"key":"750_CR44","first-page":"CD002057","volume":"10","author":"SS Shah","year":"2017","unstructured":"Shah, S. S., Ohlsson, A., Halliday, H. L. & Shah, V. S. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. Cochrane Database Syst. Rev. 10, CD002057 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR45","first-page":"CD002311","volume":"8","author":"W Onland","year":"2017","unstructured":"Onland, W., Offringa, M. & van Kaam, A. Late (>\/= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 8, CD002311 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR46","doi-asserted-by":"crossref","first-page":"L193","DOI":"10.1152\/ajplung.00528.2017","volume":"315","author":"TB Kothe","year":"2018","unstructured":"Kothe, T. B. et al. Effects of budesonide and surfactant in preterm fetal sheep. Am. J. Physiol. Lung Cell Mol. Physiol. 315, L193\u2013L201 (2018).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"750_CR47","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","volume":"121","author":"TF Yeh","year":"2008","unstructured":"Yeh, T. F. et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 121, e1310\u2013e1318 (2008).","journal-title":"Pediatrics"},{"key":"750_CR48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","volume":"193","author":"TF Yeh","year":"2016","unstructured":"Yeh, T. F. et al. Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 193, 86\u201395 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"750_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<129::AID-PPUL10>3.0.CO;2-3","volume":"26","author":"MB Fernandez-Ruanova","year":"1998","unstructured":"Fernandez-Ruanova, M. B. et al. Comparison of rapid bolus instillation with simplified slow administration of surfactant in lung lavaged rats. Pediatr. Pulmonol. 26, 129\u2013134 (1998).","journal-title":"Pediatr. Pulmonol."},{"key":"750_CR50","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1152\/jappl.2001.90.5.1955","volume":"90","author":"KJ Cassidy","year":"2001","unstructured":"Cassidy, K. J. et al. A rat lung model of instilled liquid transport in the pulmonary airways. J. Appl. Physiol. (1985) 90, 1955\u20131967 (2001).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"750_CR51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/jappl.1994.76.1.45","volume":"76","author":"T Ueda","year":"1994","unstructured":"Ueda, T., Ikegami, M., Rider, E. D. & Jobe, A. H. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J. Appl. Physiol. (1985) 76, 45\u201355 (1994).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"750_CR52","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1399-6576.1995.tb04207.x","volume":"39","author":"FJ Alvarez","year":"1995","unstructured":"Alvarez, F. J. et al. The effects of multiple small doses of exogenous surfactant on experimental respiratory failure induced by lung lavage in rats. Acta Anaesthesiol. Scand. 39, 970\u2013974 (1995).","journal-title":"Acta Anaesthesiol. Scand."},{"key":"750_CR53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00134-002-1277-7","volume":"28","author":"R Hentschel","year":"2002","unstructured":"Hentschel, R. et al. Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants. Intensive Care Med. 28, 622\u2013628 (2002).","journal-title":"Intensive Care Med."},{"key":"750_CR54","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1136\/adc.2008.149583","volume":"94","author":"KI Wheeler","year":"2009","unstructured":"Wheeler, K. I., Davis, P. G., Kamlin, C. O. & Morley, C. J. Assist control volume guarantee ventilation during surfactant administration. Arch. Dis. Child Fetal Neonatal Ed. 94, F336\u2013F338 (2009).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"750_CR55","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1542\/peds.103.2.e24","volume":"103","author":"H Verder","year":"1999","unstructured":"Verder, H. et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks\u2019 gestation. Pediatrics 103, E24 (1999).","journal-title":"Pediatrics"},{"key":"750_CR56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1460-9592.2006.02126.x","volume":"17","author":"A Kribs","year":"2007","unstructured":"Kribs, A. et al. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age <\/=27 weeks). Paediatr. Anaesth. 17, 364\u2013369 (2007).","journal-title":"Paediatr. Anaesth."},{"key":"750_CR57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/NPM-915141","volume":"9","author":"A Elmekkawi","year":"2016","unstructured":"Elmekkawi, A., Abdelgadir, D., Van, D. J., Choudhury, J. & Dunn, M. Use of naloxone to minimize extubation failure after premedication for INSURE procedure in preterm neonates. J. Neonatal Perinat. Med. 9, 363\u2013370 (2016).","journal-title":"J. Neonatal Perinat. Med."},{"key":"750_CR58","doi-asserted-by":"publisher","unstructured":"Brix, N, et al. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study. BMC Pediatr [online]. https:\/\/doi.org\/10.1186\/1471-2431-14-155 (2014).","DOI":"10.1186\/1471-2431-14-155"},{"issue":"Suppl 1","key":"750_CR59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.earlhumdev.2011.12.019","volume":"88","author":"C Dani","year":"2012","unstructured":"Dani, C., Corsini, I. & Poggi, C. Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants. Early Hum. Dev. 88(Suppl 1), 3\u20134 (2012).","journal-title":"Early Hum. Dev."},{"key":"750_CR60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00431-016-2812-9","volume":"176","author":"D Klotz","year":"2017","unstructured":"Klotz, D., Porcaro, U., Fleck, T. & Fuchs, H. European perspective on less invasive surfactant administration\u2014a survey. Eur. J. Pediatr. 176, 147\u2013154 (2017).","journal-title":"Eur. J. Pediatr."},{"key":"750_CR61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpeds.2015.11.035","volume":"170","author":"PS van der Burg","year":"2016","unstructured":"van der Burg, P. S. et al. Effect of minimally invasive surfactant therapy on lung volume and ventilation in preterm infants. J. Pediatr. 170, 67\u201372 (2016).","journal-title":"J. Pediatr."},{"key":"750_CR62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamapediatrics.2015.0504","volume":"169","author":"A Kribs","year":"2015","unstructured":"Kribs, A. et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 169, 723\u2013730 (2015).","journal-title":"JAMA Pediatr."},{"key":"750_CR63","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.3109\/14767058.2015.1136997","volume":"29","author":"E Ali","year":"2016","unstructured":"Ali, E. et al. New modalities to deliver surfactant in premature infants: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 29, 3519\u20133524 (2016).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"750_CR64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/apa.14060","volume":"107","author":"T Lamberska","year":"2018","unstructured":"Lamberska, T. et al. Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation. Acta Paediatr. 107, 73\u201378 (2018).","journal-title":"Acta Paediatr."},{"key":"750_CR65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/jp.2015.177","volume":"36","author":"JM Pinheiro","year":"2016","unstructured":"Pinheiro, J. M., Santana-Rivas, Q. & Pezzano, C. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J. Perinatol. 36, 196\u2013201 (2016).","journal-title":"J. Perinatol."},{"key":"750_CR66","doi-asserted-by":"crossref","unstructured":"Minocchieri, S., Berry, C. A. & Pillow, J. J. Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial. Arch. Dis. Child Fetal Neonatal Ed. 104, F313\u2013F319 (2018).","DOI":"10.1136\/archdischild-2018-315051"},{"key":"750_CR67","doi-asserted-by":"crossref","first-page":"F147","DOI":"10.1136\/fn.77.2.F147","volume":"77","author":"J Vyas","year":"1997","unstructured":"Vyas, J. & Kotecha, S. Effects of antenatal and postnatal corticosteroids on the preterm lung. Arch. Dis. Child 77, F147\u2013F150 (1997).","journal-title":"Arch. Dis. Child"},{"key":"750_CR68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1152\/jappl.1989.67.4.1377","volume":"67","author":"IM Gladstone","year":"1989","unstructured":"Gladstone, I. M., Mercurio, M. R., Devenny, S. G. & Jacobs, H. C. Antenatal steroids, postnatal surfactant, and pulmonary function in premature rabbits. J. Appl. Physiol. 67, 1377\u20131382 (1989).","journal-title":"J. Appl. Physiol."},{"key":"750_CR69","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0002-9378(89)90367-0","volume":"161","author":"EE Farrell","year":"1989","unstructured":"Farrell, E. E. et al. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Am. J. Obstet. Gynecol. 161, 628\u2013633 (1989).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"750_CR70","first-page":"CD000510","volume":"3","author":"MX Rojas-Reyes","year":"2012","unstructured":"Rojas-Reyes, M. X., Morley, C. J. & Soll, R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. 3, CD000510 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR71","first-page":"CD001149","volume":"2","author":"RF Soll","year":"2000","unstructured":"Soll, R. F. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst. Rev. 2, CD001149 (2000).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl 1","key":"750_CR72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/jp.2016.32","volume":"36","author":"CK Natarajan","year":"2016","unstructured":"Natarajan, C. K. et al. Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis. J. Perinatol. 36(Suppl 1), 49\u201354 (2016).","journal-title":"J. Perinatol."},{"key":"750_CR73","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-003-1276-x","volume":"162","author":"T Amizuka","year":"2003","unstructured":"Amizuka, T., Shimizu, H., Niida, Y. & Ogawa, Y. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur. J. Pediatr. 162, 697\u2013702 (2003).","journal-title":"Eur. J. Pediatr."},{"key":"750_CR74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00000542-199907000-00033","volume":"91","author":"K Nishina","year":"1999","unstructured":"Nishina, K. et al. Effects of exogenous surfactant on acute lung injury induced by intratracheal instillation of infant formula or human breast milk in rabbits. Anesthesiology 91, 240\u2013252 (1999).","journal-title":"Anesthesiology"},{"key":"750_CR75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00134-008-1321-3","volume":"35","author":"D De Luca","year":"2009","unstructured":"De Luca, D. et al. Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med. 35, 321\u2013326 (2009).","journal-title":"Intensive Care Med."},{"key":"750_CR76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1164\/ajrccm.158.1.9709041","volume":"158","author":"Z Wang","year":"1998","unstructured":"Wang, Z. & Notter, R. H. Additivity of protein and nonprotein inhibitors of lung surfactant activity. Am. J. Respir. Crit. Care Med. 158, 28\u201335 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"750_CR77","first-page":"CD003486","volume":"4","author":"S Hahn","year":"2013","unstructured":"Hahn, S., Choi, H. J., Soll, R. & Dargaville, P. A. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst. Rev. 4, CD003486 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR78","first-page":"CD005254","volume":"7","author":"A Aziz","year":"2012","unstructured":"Aziz, A. & Ohlsson, A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst. Rev. 7, CD005254 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"750_CR79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpeds.2009.07.044","volume":"156","author":"JV Been","year":"2010","unstructured":"Been, J. V. et al. Chorioamnionitis alters the response to surfactant in preterm infants. J. Pediatr. 156, 10\u201315.e1 (2010).","journal-title":"J. Pediatr."},{"key":"750_CR80","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.106.5.957","volume":"106","author":"E Herting","year":"2000","unstructured":"Herting, E. et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics 106, 957\u20136 (2000).","journal-title":"Pediatrics"},{"key":"750_CR81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1203\/00006450-199709000-00016","volume":"42","author":"LJ Bj\u00f6rklund","year":"1997","unstructured":"Bj\u00f6rklund, L. J. et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr. Res. 42, 348\u2013355 (1997).","journal-title":"Pediatr. Res."},{"key":"750_CR82","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/01.CCM.0000114578.48244.21","volume":"32","author":"AH van Kaam","year":"2004","unstructured":"van Kaam, A. H. et al. Response to exogenous surfactant is different during open lung and conventional ventilation. Crit. Care Med. 32, 774\u2013780 (2004).","journal-title":"Crit. Care Med."},{"key":"750_CR83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.107.2.363","volume":"107","author":"G Moriette","year":"2001","unstructured":"Moriette, G. et al. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome. Pediatrics 107, 363\u2013372 (2001).","journal-title":"Pediatrics"},{"key":"750_CR84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-3476(05)82057-8","volume":"119","author":"LS Goldsmith","year":"1991","unstructured":"Goldsmith, L. S. et al. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention. J. Pediatr. 119, 424\u2013428 (1991).","journal-title":"J. Pediatr."},{"key":"750_CR85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/japplphysiol.00609.2003","volume":"97","author":"JC Anderson","year":"2004","unstructured":"Anderson, J. C., Molthen, R. C., Dawson, C. A. & Haworth, S. T. Effect of ventilation rate on instilled surfactant distribution in the pulmonary airways of rats. J. Appl. Physiol. 97, 45\u201356 (2004).","journal-title":"J. Appl. Physiol."},{"key":"750_CR86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1164\/rccm.201103-0375OC","volume":"184","author":"M Miedema","year":"2011","unstructured":"Miedema, M. et al. Changes in lung volume and ventilation during surfactant treatment in ventilated preterm infants. Am. J. Respir. Crit. Care Med. 184, 100\u2013105 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0750-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:01:00Z","timestamp":1744077660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0750-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-0750-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}